GL1X · GenesisL1 explorer

Research workbench

Human PLK1-pbd in complex with poloxime ((E)-4-(hydroxyimino)-2- isopropyl-5-methylcyclohexa-2,5-dienone)

Analyse Human PLK1-pbd in complex with poloxime ((E)-4-(hydroxyimino)-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4H71
Type
protein
Length
438 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
SERINE/THREONINE-protein kinase PLK1
EC
2.7.11.21
UniProt
P53350
Ligands
PXE
Pockets
5 · best druggability 0.60

Structure

x-ray diffraction · 2 distinct chains · 32% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BSERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein21634% helix, 30% strandP53350
ASERINE/THREONINE-protein kinase PLK1 (EC 2.7.11.21)protein22230% helix, 29% strandP53350

Ligands and binding sites

  • PXE · 2-methyl-5-(1-methylethyl)cyclohexa-2,5-diene-1,4-dione 1-oxime · ligand · chains A
  • GOL · Glycerol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12360.600.8028empty
21460.440.7623GOL, PXE
31360.420.7523empty
4540.370.8014empty
5570.300.7513empty

Interfaces

1 interface between chains.

  • B–A · 334 Ų buried · 3 hydrogen bonds · protein-protein

Compared structures

  • 4H71 · Human Plk1-PBD in complex with Poloxime ((E)-4-(hydroxyimino)-2-isopropyl-5-methylcyclohex… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.